Literature DB >> 19263379

[Vaccination against bluetongue: safety and immune response in the field].

L Bruckner1, R Fricker, M Hug, R Hotz, J Muntwyler, C Iten, C Griot.   

Abstract

Bluetongue, caused by the bluetongue virus serotype 8 has rapidly spread through Europe since 2006. The first cases in Switzerland were detected in October 2007. The European Union and Switzerland launched a vaccination campaign in June 2008. This study aims to demonstrate the safety and the immune response of the three vaccines used in Switzerland under practical conditions in the field. The trial was carried out in cattle, sheep and goats. Based on the results of this study recommendations for the 2009 campaign are presented.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19263379     DOI: 10.1024/0036-7281.151.3.101

Source DB:  PubMed          Journal:  Schweiz Arch Tierheilkd        ISSN: 0036-7281            Impact factor:   0.845


  3 in total

1.  Three years of bluetongue disease in central Europe with special reference to Germany: what lessons can be learned?

Authors:  Helge Kampen; Doreen Werner
Journal:  Wien Klin Wochenschr       Date:  2010-10       Impact factor: 1.704

2.  Financial evaluation of different vaccination strategies for controlling the bluetongue virus serotype 8 epidemic in The Netherlands in 2008.

Authors:  Annet G J Velthuis; Monique C M Mourits; Helmut W Saatkamp; Aline A de Koeijer; Armin R W Elbers
Journal:  PLoS One       Date:  2011-05-04       Impact factor: 3.240

3.  Survey of bluetongue virus infection in free-ranging wild ruminants in Switzerland.

Authors:  Julien Casaubon; Valérie Chaignat; Hans-Rudolf Vogt; Adam O Michel; Barbara Thür; Marie-Pierre Ryser-Degiorgis
Journal:  BMC Vet Res       Date:  2013-08-14       Impact factor: 2.741

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.